يعرض 1 - 10 نتائج من 30 نتيجة بحث عن '"Dingemans, A. C."', وقت الاستعلام: 0.97s تنقيح النتائج
  1. 1
    دورية أكاديمية

    المصدر: Jebbink , M , de Langen , A J , Monkhorst , K , Boelens , M C , van den Broek , D , van der Noort , V , de Gooijer , C J , Mahn , M , van der Wekken , A J , Hendriks , L , Hashemi , S M S , Paats , M S , Dingemans , A C & Smit , E F 2023 , ' Trastuzumab-Emtansine and Osimertinib Combination Therapy to Target HER2 Bypass Track Resistance in EGFR Mutation-Positive NSCLC ' , JTO Clinical and Research Reports , vol. ....

  2. 2
    دورية أكاديمية
  3. 3
    دورية أكاديمية
  4. 4
    دورية أكاديمية

    المصدر: Morfouace , M , Novello , S , Stevovic , A , Dooms , C , Janžič , U , Berghmans , T , Dziadziuszko , R , Gorlia , T , Felip , E , Paz-Ares , L , Mazieres , J , O’Brien , M , Bironzo , P , Vansteenkiste , J , Lacroix , L , Dingemans , A C , Golfinopoulos , V & Besse , B 2022 , ' Results of screening in early and advanced thoracic malignancies in the EORTC pan-European SPECTAlung platform ' , Scientific Reports , vol. 12 , no. ....

    وصف الملف: application/pdf

  5. 5
    دورية أكاديمية

    المصدر: de Joode , K , Dumoulin , D W , Engelen , V , Bloemendal , H J , Verheij , M , van Laarhoven , H W M , Dingemans , I H , Dingemans , A C & van der Veldt , A A M 2020 , ' Impact of the coronavirus disease 2019 pandemic on cancer treatment : the patients' perspective ' , European Journal of Cancer , vol. 136 , pp. 132-139 . https://doi.org/10.1016/j.ejca.2020.06.019Test

  6. 6
    دورية أكاديمية

    المساهمون: Netherlands Cancer Institute, Amsterdam, Netherlands

    العلاقة: https://dx.doi.org/10.1016/s0140-6736Test(23)00221-0; de Langen AJ, Johnson ML, Mazieres J, Dingemans AC, Mountzios G, Pless M, et al. Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRAS(G12C) mutation: a randomised, open-label, phase 3 trial. Lancet. 2023 Mar 4;401(10378):733-46. PubMed PMID: 36764316. Epub 2023/02/11. eng.; http://hdl.handle.net/10541/626058Test; Lancet

  7. 7
    دورية أكاديمية

    المساهمون: Department of Oncology, University of Verona Hospital Trust, Verona, Italy

    العلاقة: https://dx.doi.org/10.1016/j.lungcan.2022.05.009Test; Pilotto S, Avancini A, Menis J, Sperduti I, Giaj Levra M, Berghmans T, et al. Exercise in lung Cancer, the healthcare providers opinion (E.C.H.O.): Results of the EORTC lung cancer Group (LCG) survey. Vol. 169, Lung Cancer. Elsevier BV; 2022. p. 94–101.; http://hdl.handle.net/10541/625370Test; Lung Cancer

  8. 8

    المساهمون: Pulmonary Medicine, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, MUMC+: KIO Kemta (9), RS: CAPHRI - R2 - Creating Value-Based Health Care, RS: NUTRIM - R3 - Respiratory & Age-related Health, Pulmonologie, RS: GROW - R2 - Basic and Translational Cancer Biology, Precision Medicine, Maastro clinic, Radiotherapie

    المصدر: Radiotherapy and Oncology, 183:109417. Elsevier Ireland Ltd

    وصف الملف: application/pdf

  9. 9
    دورية أكاديمية

    المساهمون: Department of Pulmonology, Erasmus Medical Center, Rotterdam, Department of Pulmonology, GROW School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands

    العلاقة: https://dx.doi.org/10.1016/j.annonc.2021.03.207Test; Dingemans A-MC, Früh M, Ardizzoni A, Besse B, Faivre-Finn C, Hendriks LE, et al. Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆. Annals of Oncology. 2021 Apr; http://hdl.handle.net/10541/624036Test; Annals of Oncology

  10. 10
    دورية أكاديمية

    المصدر: O'Brien , M , Jassem , J , Lorigan , P , Bosquée , L , Marshall , E , Bustin , F , Stigt , J , Dingemans , A C , Hasan , B & Van Meerbeeck , J P 2017 , ' Randomized phase II study (EORTC 08062) of amrubicin as single agent or in combination with cisplatin versus etoposide-cisplatin as first-line treatment in patients (pts) with extensive disease small cell lung cancer (ED SCLC). ' , Journal of Clinical Oncology , vol. 28 , no. 15_suppl , pp. 7052-7052 . https://doi.org/10.1200/jco.2010.28.15_suppl.7052Test